Viral vectors for treating neurogenic detrusor overactivity
US11414666B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 23, 2017 |
| Grant date | Aug 16, 2022 |
| Priority date | — |
| Expiry date | Feb 18, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method and a pharmaceutical composition for the treatment of the NDO comprising the viral expression vector carrying a transcription cassette that harbors transgene(s) inhibiting/silencing neurotransmission or synaptic transmission of afferent neurons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.